Department of Neurodegenerative Science

6 results.

April 14, 2025 University of Minnesota, Van Andel Institute receive two-year, $5.8M grant to study Parkinson’s disease and cellular senescence

GRAND RAPIDS, Mich. (April 14, 2025) — Aging is the most important risk factor for neurodegenerative diseases, including Parkinson’s disease. However, the connection between aging…

February 7, 2025 After the recent exenatide results, what’s next in Parkinson’s disease research and clinical trials?

Earlier this week, The Lancet published results of a phase 3 clinical trial that explored whether the Type 2 diabetes medication exenatide could…

December 20, 2024 Van Andel Institute appoints Dr. Darren Moore as Jay Van Andel Endowed Chair in Parkinson’s Disease Research

GRAND RAPIDS, Mich. (Dec. 20, 2024) — Van Andel Institute has appointed leading Parkinson’s scientist Darren Moore, Ph.D., as the Jay Van Andel Endowed Chair in…

January 11, 2024 ‘A Grand Plan' for achieving breakthroughs and improving health

Collaboration, innovation and robust science are a powerful combination, one that drives discoveries aimed at improving health for generations to come. The era of siloed…

March 22, 2018 Meet the scientist behind the science: Dr. Darren Moore

Dr. Darren Moore leads a lab in Van Andel Research Institute’s Center for Neurodegenerative Science. His team is working to uncover the genetic causes of…

April 25, 2017 In their words: The future of Parkinson’s disease research

In honor of Parkinson’s Awareness Month and the 200th anniversary of Dr. James Parkinson’s An Essay on the Shaking Palsy, we asked scientists in…